FIELD: chemistry.
SUBSTANCE: primary neuron cultures or primary glial cells are cultured. The compound under test is added. Survival rate of the cultured neurons or proliferation of the cultured glial cells is evaluated.
EFFECT: invention increases rate of screening compounds, enables search for new compounds with the highest activity which are potential neuroprotectors.
6 cl, 4 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSMENT OF NEUROTROPHIN GENES EXPRESSION | 2009 |
|
RU2383619C1 |
METHOD FOR ASSESSING NEUROPROTECTIVE PROPERTIES OF VITRO SUBSTANCES AND THE TEST SYSTEM FOR ITS IMPLEMENTATION | 2016 |
|
RU2646446C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC INSULT AND METHOD FOR THERAPY | 2002 |
|
RU2251429C2 |
PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS | 2004 |
|
RU2380410C2 |
METHOD FOR PREPARING A NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM NEURONS AND GLIAL CELLS OBTAINED BY DIRECTIONAL DIFFERENTIATION OF INDUCED HUMAN PLURIPOTENT STEM CELLS | 2018 |
|
RU2690498C1 |
METHOD FOR SIMULATING TISSUE STRUCTURE OF HUMAN RETINA | 2012 |
|
RU2486603C1 |
NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM NEURONS AND GLIAL CELLS OBTAINED BY DIRECTED DIFFERENTIATION OF INDUCED HUMAN PLURIPOTENT STEM CELLS | 2018 |
|
RU2690846C1 |
METHOD FOR PRODUCING NEURONAL MATRIX | 2010 |
|
RU2431666C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEUROLOGIC DISEASES | 2007 |
|
RU2335296C1 |
METHOD OF PREPARING HUMAN EMBRYONAL NEURONS PREPARATION FOR CYTOTRANSFUSION | 1998 |
|
RU2146932C1 |
Authors
Dates
2010-03-10—Published
2009-03-12—Filed